Skye Global Management’s Renalytix plc American Depositary Shares RNLX Stock Holding History

Skye Global Management’s Portfolio RNLX Stock Details RNLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-17,200	Closed	-$119K	–	33
2022 Q1	$119K	Buy	17,200 +10,600	+161%	+$112K	﹤0.01%	30
2021 Q4	$105K	Buy	+6,600	New	+$132K	﹤0.01%	49
2021 Q3	–	Sell	-39,000	Closed	-$1.2M	–	78
2021 Q2	$1.2M	Buy	39,000 +17,000	+77%	+$509K	0.02%	48
2021 Q1	$565K	Buy	+22,000	New	+$551K	0.01%	59

Other funds holding RNLX

GGHC

Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return

PCM

Philosophy Capital Management Alamo, California $1.63B AUM 12.69% 1-Year Est. Return

GKIM

GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return

PGM

Parian Global Management Pound Ridge, New York $30.8M AUM 51.25% 1-Year Est. Return

Pinnacle Associates New York $7.78B AUM 45.07% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

Gofen & Glossberg Chicago, Illinois $3.89B AUM 11.97% 1-Year Est. Return

Skye Global Management's RNLX Position: Q2 2022 in Review

Skye Global Management sold out of Renalytix plc American Depositary Shares (RNLX) in Q2 2022, closing a stake of 17,200 shares — an estimated $119K sold.

Skye Global Management first reported a position in RNLX in Q1 2021 and held it in 4 quarters. The position peaked at $1.2M in Q2 2021. 31 funds tracked by Wall St. Rank hold RNLX as of Q2 2022.

Skye Global Management reported no remaining Renalytix plc American Depositary Shares position as of Q2 2022 after selling out during the quarter.
Skye Global Management sold 17,200 Renalytix plc American Depositary Shares shares in Q2 2022, an estimated $119K.
Skye Global Management first reported a position in Renalytix plc American Depositary Shares in Q1 2021 and held it in 4 quarters.
Skye Global Management's Renalytix plc American Depositary Shares position peaked at $1.2M in Q2 2021.
31 funds tracked by Wall St. Rank held Renalytix plc American Depositary Shares as of Q2 2022.

Based on Skye Global Management's 13F filing for Q2 2022, filed 15 Aug 2022.